Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin vs Amitriptyline for Migraine Prevention (EDUMAP)
NCT01357031Phase 3Completed
- Sponsor
- Hospital Israelita Albert Einstein
- Start
- May 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of melatonin in migraine (3 arms), sponsored by Hospital Israelita Albert Einstein. Primary endpoint: Change in number of headache days from baseline to month 3. Started May 2010; status: completed.
02
Drugs
melatonin
03
Conditions
migraine
Beyond the preview
Go deeper on NCT01357031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01357031.